Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118306) titled 'COPD Exacerbation Follow Up' on Aug. 1.
Study Type: Observational
Primary Sponsor: Viz.ai, Inc.
Condition:
COPD (Chronic Obstructive Pulmonary Disease)
Recruitment Status: Not recruiting
Date of First Enrollment: October 2025
Target Sample Size: 485
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118306
Published by HT Digital Content Services with permission from Health Daily Digest....